FDA Approves Groundbreaking Gene Therapy for Cancer - MIT Technology Review

MIT Technology Review
FDA Approves Groundbreaking Gene Therapy for Cancer
MIT Technology Review
A revolutionary cancer therapy that uses genetically engineered immune cells has been approved by the U.S. Food and Drug Administration, ushering in a new era of cancer treatment. The FDA calls the treatment, marketed by Novartis, the “first gene ...
FDA approval brings first gene therapy to the United StatesFDA.gov
Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM)